ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,396Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 569

$400K Total Retail Price of All Prescriptions

Rank: 79 out of 569

504 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 348 309 91 1 1
LISINOPRIL 294 255 87 2 2
SIMVASTATIN 274 242 77 3 3
HYDROCHLOROTHIAZIDE 272 244 73 4 8
AMLODIPINE BESYLATE 205 190 50 5 6
METFORMIN HCL 191 151 46 6 5
OMEPRAZOLE 159 136 45 7 4
METOPROLOL SUCCINATE 115 110* 28 8 15
LOSARTAN POTASSIUM 113 108* 33 9 13
LOVASTATIN 112 100 31 10 12
FLUOXETINE HCL 108 66 26 11 39
HYDROCODONE-ACETAMINOPHEN 108 73 24 S3 11 7
ATENOLOL 107 102* 29 13 19
ZOLPIDEM TARTRATE 107 79 26 13 18
FLUTICASONE PROPIONATE 103 98* 36 15 17
PANTOPRAZOLE SODIUM 96 91* 25 16 36
LORAZEPAM 89 77 29 B 17 41
RANITIDINE HCL 87 82* 19 18 29
METOPROLOL TARTRATE 75 70* 18 19 14
PROAIR HFA 74 63 33 20 30
GABAPENTIN 66 47 22 21 9
PRAVASTATIN SODIUM 65 46 19 22 33
TRAZODONE HCL 62 48 21 23 24
BD ULTRA-FINE PEN NEEDLE 57 52* 20 24 123
FUROSEMIDE 56 51* 20 25 11
POTASSIUM CHLORIDE 56 51* 15 25 26
TAMSULOSIN HCL 55 50* 12 27 22
ALENDRONATE SODIUM 55 43 11 27 16
LANTUS SOLOSTAR 54 38 15 29 89
CITALOPRAM HBR 53 48* 15 30 23
PROPRANOLOL HCL 51 39 11 31 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 45* 18 32 21
SPIRIVA 50 <11 <11 32 71
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.